譽衡藥業(002437.SZ):譽衡國際及一致行動人擬減持不超6%股份
格隆匯9月8日丨譽衡藥業(002437.SZ)公佈,公司持股5%以上股東YU HENG INTERNATIONAL INVESTMENTS CORPORATION(以下簡稱“譽衡國際”)及其一致行動人ORIENTAL KEYSTONE INVESTMENT LIMITED(以下簡稱“健康科技”)債權人可能對持有的公司股票進行處置導致其被動減持。此外,譽衡國際、健康科技可能通過減持公司股票方式化解其債務壓力和流動性風險。
譽衡國際、健康科技及其債權人在未來六個月內通過證券交易系統包括但不限於集中競價交易、大宗交易等合法方式減持其持有的公司股份合計不超過1.32億股(佔公司總股本的6.00%,若此期間有股份變動事項,則對該數量進行相應調整)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.